Question 1

What is the share price of Cohance Lifesciences Limited today?

Accepted Answer

Cohance Lifesciences Limited (COHANCE) is trading at ₹481.35. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is COHANCE’s P/E ratio versus the sector?

Accepted Answer

COHANCE trades at a P/E of 89.0. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is COHANCE’s dividend yield?

Accepted Answer

COHANCE has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is COHANCE’s 52-week high and low?

Accepted Answer

COHANCE has traded between ₹266.7 and ₹794.75 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Cohance Lifesciences Limited?

Accepted Answer

Cohance Lifesciences Limited has a market capitalisation of ₹17,005 crore.

Question 6

What is COHANCE’s return on equity?

Accepted Answer

COHANCE reports a return on equity of 5.7%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.

Question 7

Who are COHANCE’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is COHANCE’s promoter holding?

Accepted Answer

Promoters hold 57.49% of COHANCE. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include COHANCE?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight COHANCE carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Cohance Lifesciences Limited a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from COHANCE’s own numbers. The judgement is yours.

Revenue	₹2,030 crore
Net profit	₹229 crore
Operating margin	22%
EPS	₹5.98

COHANCE

COHANCE

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

COHANCE financial summary